Sign in

Royalty Pharma plc

Income Statement - Royalty Pharma plc (RPRX)

$(Billion, Million)
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total revenue 2.38 2.26 2.35 2.24 2.29 2.12 1.81 1.79 1.60 1.88 1.65 0.00 0.00
Cost of revenue 0.00 0.73 0.56 0.90 0.45 0.23 1.02 0.14 0.03 0.00 0.00 0.00 0.01 0.03 0.03
Gross profit 2.38 2.26 2.35 2.24 2.29 2.12 1.81 1.79 1.60 1.88 1.65 0.00
Total operating expenses + 0.82 0.97 0.86 1.93 0.86 0.53 -0.81 0.43 0.66 1.09 0.79 0.00
Operating income 1.56 1.29 1.49 0.31 1.43 1.60 2.62 1.36 0.94 0.72 0.79 -0.03
Non-operating income (net) -0.24 0.04 0.21 -0.08 -0.19 0.11 -0.16 0.15 0.40 0.04 -0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax 1.32 1.33 1.70 0.23 1.24 1.70 2.46 1.52 1.34 0.76 0.76 -0.03
Income tax expense 0.55 0.47 0.57 0.19 0.76 1.15 0.35 0.43 0.54 0.20 0.18 0.00
Net income 0.77 0.86 1.13 0.04 0.62 0.98 2.35 1.38 1.21 0.57 0.58 -0.03
Show Quarterly Income Statement

Income Statement - Royalty Pharma plc (RPRX)

$(Billion, Million)
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06 Dec-05 Sep-05 Jun-05 Mar-05 Dec-04
Total revenue 0.63 0.62 0.61 0.58 0.57 0.59 0.56 0.54 0.57 0.60 0.54 0.54 0.68 0.57 0.57 0.54 0.56 0.58 0.59 0.55 0.57 0.57 0.54 0.51 0.50 0.46 0.46 0.46 0.43 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.20 0.13 0.16 0.23 0.01 0.58 0.08 0.28 0.24 0.12 0.31 0.31 0.11 0.18 0.27 0.14 0.01 0.29 0.13 0.01 0.01 0.09 0.92 0.12 0.07 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00
Gross profit 0.63 0.62 0.61 0.58 0.57 0.59 0.56 0.54 0.57 0.60 0.54 0.54 0.68 0.57 0.57 0.54 0.56 0.58 0.59 0.55 0.57 0.57 0.54 0.51 0.50 0.46 0.46 0.46 0.43 0.00 0.00 0.00 0.00
Total operating expenses + 0.00 0.23 0.18 0.37 0.03 0.23 -0.17 0.27 0.64 -0.02 0.38 0.29 0.20 1.05 0.38 0.16 0.34 0.42 0.28 -0.19 0.34 0.26 0.03 0.10 0.14 -0.87 -0.07 0.13 0.00 0.00 0.00 0.00 0.00
Operating income 0.63 0.39 0.43 0.21 0.53 0.36 0.74 0.27 -0.07 0.61 0.15 0.25 0.48 -0.48 0.19 0.38 0.22 0.15 0.30 0.74 0.23 0.31 0.51 0.41 0.36 1.33 0.53 0.33 0.43 0.00 0.00 -0.01 0.00
Non-operating income (net) -0.16 -0.03 0.02 -0.12 -0.10 -0.03 0.07 -0.08 0.07 0.10 -0.03 0.10 0.03 -0.13 0.03 0.11 -0.09 -0.10 -0.08 0.06 -0.07 0.05 0.11 0.19 -0.25 0.11 -0.09 -0.15 -0.03 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax 0.47 0.36 0.44 0.09 0.43 0.33 0.81 0.19 0.00 0.72 0.12 0.35 0.51 -0.61 0.22 0.49 0.13 0.05 0.22 0.81 0.16 0.37 0.62 0.60 0.11 1.45 0.44 0.18 0.40 0.00 0.00 -0.01 0.00
Income tax expense 0.17 0.14 0.16 0.06 0.13 0.26 0.09 -0.01 0.22 0.05 0.12 0.17 0.00 0.00 0.19 0.17 0.05 0.12 0.37 0.09 -0.53 0.33 0.16 0.08 0.08 0.09 0.09 0.09 0.00 0.00 0.00 0.00
Net income 0.30 0.21 0.29 0.03 0.24 0.21 0.54 0.10 0.00 0.49 0.07 0.23 0.34 -0.46 0.14 0.30 0.05 0.01 0.10 0.44 0.07 0.17 0.29 0.44 0.07 1.42 0.41 0.15 0.37 0.00 0.00 -0.01 0.00
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Total cash and short-term investments + 0.64 1.77 1.23 2.43 2.80 1.99 0.79 2.39 1.38 1.67 1.72 0.05 0.08 0.02 0.00 0.00 0.00 0.02 0.03 0.01
Accounts receivable, net 0.88 0.03 0.02 0.04 0.07 0.04 0.04 0.20
Inventories 0.00 0.00 0.66 0.02
Other current assets -0.90 0.00 0.02 0.09 0.01 0.01 0.00 0.02 1.57 1.33 1.32 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.62 1.80 1.27 2.55 2.88 2.70 0.83 2.61 2.95 3.00 3.04 0.05
Total non-current assets + 17.06 16.42 15.11 14.26 14.64 13.32 11.62 8.76 8.43 7.48 7.77
Total assets 19.62 18.22 16.38 16.81 17.52 21.10 12.45 11.37 11.37 10.48 10.82 0.05 0.08 0.03 0.01 0.00 0.00 0.02 0.03 0.01
Total current liabilities + 0.64 1.25 0.16 1.17 0.17 0.31 0.33 0.58 0.38 0.30 0.31 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Total non-current liabilities + 9.27 6.63 6.14 6.12 7.10 5.82 5.98 6.24 6.52 5.72 5.80
Total liabilities 9.91 7.88 6.30 7.29 7.27 6.12 6.31 6.82 6.90 6.02 6.12 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.00 0.00
Total stockholders' equity + 6.48 6.95 6.53 5.63 10.25 14.97 6.11 4.49 4.46 4.45 4.68 0.04 0.08 0.02 0.00 0.00 0.00 0.02 0.02 0.00
Common shares outstanding 560 594 603 565 415 375 354 354 354 607 607 354 354 354 354 354 354 354 354 354
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Jun-16 Mar-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06 Dec-05 Sep-05 Jun-05 Mar-05 Dec-04
Total cash and short-term investments + 0.61 0.64 0.96 1.49 1.82 1.77 1.76 2.55 1.53 1.23 1.68 2.91 2.59 2.43 2.22 3.40 2.91 2.80 2.69 2.65 2.37 1.99 2.13 3.34 1.70 0.79 0.00 0.00 1.94 0.00 0.00 0.00 0.01 0.01 0.01 0.02 0.02 0.03 0.03 0.04 0.05 0.05 0.06 0.07 0.08 0.08 0.09 0.02 0.02 0.03 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.01 0.00 0.00 0.00 0.00 0.01 0.02 0.01 0.01 0.02 0.03 0.03 0.03 0.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts receivable, net 0.81 0.88 0.89 0.03 0.02 0.03 0.02 0.02 0.02 0.02 0.04 0.04 0.04 0.04 0.03 0.04 0.07 0.07 0.07 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Inventories -0.79 0.00 0.00 0.00 0.00 0.00 0.00 0.66 0.60
Other current assets 0.01 -0.90 0.01 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.01 0.01 0.00 0.09 0.09 0.07 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 1.43 0.62 1.85 1.52 1.84 1.80 1.79 2.58 1.56 1.27 1.73 2.95 2.63 2.55 2.34 3.50 2.98 2.88 2.78 2.71 2.42 2.70 2.78 3.39 1.74 0.83 1.94 0.00 0.00 0.00 0.01
Total non-current assets + 18.39 17.06 17.50 16.80 15.77 16.42 16.25 15.08 14.57 15.11 14.13 14.17 14.44 14.26 15.33 14.24 14.40 14.64 14.96 13.81 13.50 13.32 13.21 12.29 11.63 11.62 -1.94
Total assets 19.82 19.62 19.35 18.32 17.61 18.22 18.04 17.66 16.13 16.38 15.86 17.12 17.07 16.81 17.67 17.74 17.38 17.52 17.73 16.51 15.91 21.10 21.34 15.69 13.37 12.45 0.00 0.01 0.01 0.01 0.01 0.01 0.02 0.02 0.03 0.03 0.04 0.05 0.06 0.06 0.07 0.08 0.08 0.09 0.02 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.01 0.01 0.00 0.00 0.00 0.01 0.02 0.02 0.01 0.02 0.02 0.03 0.03 0.03 0.04 0.01 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.01
Total current liabilities + 0.54 0.64 0.53 1.21 1.18 1.25 1.17 0.28 0.12 0.16 0.13 1.17 1.12 1.17 1.13 0.18 0.14 0.17 0.26 0.28 0.26 0.31 0.27 0.45 0.43 0.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total non-current liabilities + 9.34 9.27 9.20 7.61 6.64 6.63 6.62 7.63 6.14 6.14 6.14 6.14 6.14 6.12 6.12 7.15 7.10 7.10 7.09 5.83 5.82 5.82 5.92 5.84 5.77 5.98
Total liabilities 9.88 9.91 9.73 8.82 7.82 7.88 7.78 7.90 6.27 6.30 6.27 7.31 7.25 7.29 7.26 7.33 7.24 7.27 7.35 6.11 6.08 6.12 6.19 6.29 6.21 6.31 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total stockholders' equity + 6.89 6.48 6.41 6.35 6.69 6.95 6.87 6.48 6.50 6.53 6.14 6.28 5.95 5.63 6.15 6.03 5.78 5.78 5.79 5.73 4.88 9.90 9.80 4.16 5.16 6.11 4.55 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.02 0.02 0.03 0.04 0.04 0.05 0.06 0.07 0.08 0.08 0.09 0.02 0.02 0.03 0.01 0.01 0.00 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.02 0.01 0.01 0.02 0.02 0.03 0.03 0.03 0.00 0.01 0.01 0.02 0.02 0.02 0.02 0.02 0.01
Common shares outstanding 560 560 560 562 578 589 593 597 597 602 601 606 607 523 607 607 607 607 607 607 607 388 370 354 351 352 354 354 354 323 275 269 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249 249
about 2 months ago
Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16 Dec-15 Dec-14 Dec-13 Dec-12 Dec-11 Dec-10 Dec-09 Dec-08 Dec-07 Dec-06
Operating cash flow + 2.49 2.77 2.99 2.14 2.02 2.03 1.67 1.62 1.42 -0.02 -0.03 -0.03
Cash flow from investing + -1.61 -2.68 -2.07 -1.03 -1.87 -2.76 -2.15 0.30 -1.59 0.02
Cash flow from financing + -1.19 0.36 -2.15 -0.94 0.39 1.49 -1.19 -1.38 -0.12 0.00 0.00 0.00 0.08 0.03 0.01 0.01 0.00 0.02 0.03 0.00
Change in cash -0.31 0.45 -1.23 0.17 0.53 0.76 -1.68 0.54 -0.29 -0.01 -0.03 -0.03 0.08 0.03 0.01 0.01 0.00 0.04 0.03 0.00
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23 Sep-23 Jun-23 Mar-23 Dec-22 Sep-22 Jun-22 Mar-22 Dec-21 Sep-21 Jun-21 Mar-21 Dec-20 Sep-20 Jun-20 Mar-20 Dec-19 Sep-19 Jun-19 Mar-19 Sep-17 Jun-17 Mar-17 Dec-16 Sep-16 Dec-15 Sep-15 Jun-15 Mar-15 Dec-14 Sep-14 Jun-14 Mar-14 Dec-13 Sep-13 Jun-13 Mar-13 Dec-12 Sep-12 Jun-12 Mar-12 Dec-11 Sep-11 Jun-11 Mar-11 Dec-10 Sep-10 Jun-10 Mar-10 Dec-09 Sep-09 Jun-09 Mar-09 Dec-08 Sep-08 Jun-08 Mar-08 Dec-07 Sep-07 Jun-07 Mar-07 Dec-06 Sep-06 Jun-06 Mar-06 Dec-05 Sep-05 Jun-05 Mar-05 Dec-04 Sep-04 Jun-04
Operating cash flow + 0.76 0.83 0.70 0.36 0.60 0.74 0.70 0.66 0.66 0.77 0.57 0.61 1.03 0.57 0.54 0.57 0.46 0.49 0.47 0.53 0.53 0.57 0.51 0.49 0.47 0.48 0.42 0.34 0.43 0.00 0.00 0.00 0.00 0.00
Cash flow from investing + -0.52 -0.85 -0.96 -0.31 0.50 -0.51 -1.19 -0.89 -0.09 -1.00 -0.45 -0.06 -0.56 0.41 -1.43 -0.03 0.01 -0.55 -0.85 0.13 -0.60 -0.83 -0.92 -0.24 -0.76 -0.03 -0.62 -0.16 -1.32 0.02 0.02 0.02 0.02
Cash flow from financing + -0.27 -0.30 0.56 -0.51 -0.94 -0.26 -0.33 1.16 -0.21 -0.23 -1.36 -0.35 -0.21 -0.27 -0.23 -0.23 -0.22 -0.20 1.03 -0.22 -0.23 -0.28 -0.36 1.58 0.54 -0.29 -0.28 -0.31 -0.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.08 0.08 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.02 0.00 0.03 0.03 0.03 0.03 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02
Change in cash -0.03 -0.32 0.31 -0.46 0.16 -0.02 -0.81 0.92 0.37 -0.46 -1.24 0.20 0.26 0.72 -1.12 0.32 0.25 -0.26 0.66 0.43 -0.30 -0.54 -0.77 1.82 0.25 0.17 -0.48 -0.13 -1.20 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.08 0.08 0.08 0.00 0.03 0.03 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.00 0.00 0.00 0.00 0.00 0.04 0.02 0.02 0.02 0.03 0.03 0.03 0.03 0.00 0.00 0.00 0.00 0.02 0.02 0.02 0.02 0.00 0.00 0.00
about 2 months ago

Royalty Pharma plc (RPRX) - Change In Cash And Cash Equivalents

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Change In Inventory

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Net Income

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Stock Based Compensation

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Proceeds From Repurchase Of Equity

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Dividend Payout

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Cashflow From Financing

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Cashflow From Investment

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Capital Expenditures

1Y 2Y 5Y Max
about 2 months ago

Royalty Pharma plc (RPRX) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
about 2 months ago